KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Short-term Investments (2020 - 2025)

Biolife Solutions (BLFS) has disclosed Short-term Investments for 7 consecutive years, with $55.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-term Investments rose 507.62% to $55.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $55.9 million, a 507.62% increase, with the full-year FY2025 number at $55.9 million, up 507.62% from a year prior.
  • Short-term Investments was $55.9 million for Q4 2025 at Biolife Solutions, up from $49.5 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $55.9 million in Q4 2025 to a low of $10000.0 in Q4 2021.
  • A 5-year average of $15.3 million and a median of $118500.0 in 2021 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: surged 432500.0% in 2022, then tumbled 99.91% in 2023.
  • Biolife Solutions' Short-term Investments stood at $10000.0 in 2021, then soared by 432500.0% to $43.3 million in 2022, then crashed by 62.35% to $16.3 million in 2023, then tumbled by 43.53% to $9.2 million in 2024, then skyrocketed by 507.62% to $55.9 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Short-term Investments are $55.9 million (Q4 2025), $49.5 million (Q3 2025), and $49.9 million (Q2 2025).